Who Owns Immuneering Stock?
NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 58.04%
- Held by insiders
- 14.24%
- Institutional holders
- 163
- Institutions 58.0%
- Insiders 14.2%
- Public and other 27.7%
Who owns Immuneering stock?
Institutional investors own about 58.0% of Immuneering's shares, spread across 163 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 14.24% of IMRX.
The largest institutional holders are FMR, LLC (14.20%), Blackrock Inc. (6.75%) and Sanofi (4.18%). Together, the top 10 institutions control 39.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their IMRX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 9.19M | 14.20% | -5.3% |
| Blackrock Inc. | 4.37M | 6.75% | +190.2% |
| Sanofi | 2.71M | 4.18% | 0.0% |
| Vanguard Capital Management LLC | 2.29M | 3.53% | -0.1% |
| Price (T.Rowe) Associates Inc | 1.94M | 2.99% | +5.8% |
| Geode Capital Management, LLC | 1.37M | 2.12% | +0.3% |
| State Street Corporation | 1.15M | 1.78% | +15.0% |
| Nuveen, LLC | 869.39K | 1.34% | +98.3% |
| DCF Advisers, LLC | 862.50K | 1.33% | +9.2% |
| Aberdeen Group plc | 784.95K | 1.21% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.93M | 4.53% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.62M | 2.51% |
| iShares Trust-iShares Russell 2000 ETF | 1.42M | 2.20% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.10M | 1.69% |
| T. Rowe Price New Horizons Fund, Inc. | 906.76K | 1.40% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 681.21K | 1.05% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 612.34K | 0.95% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 594.40K | 0.92% |
| iShares Trust-iShares Russell 2000 Value ETF | 530.88K | 0.82% |
| iShares Trust-iShares Biotechnology ETF | 449.08K | 0.69% |
Frequently asked questions
Who is the largest shareholder of Immuneering?
FMR, LLC is the largest institutional shareholder of IMRX, owning 14.20% of shares outstanding (9.19M shares) as of its latest 13F filing.
What percentage of Immuneering is owned by institutions?
Institutions own about 58.0% of IMRX shares and 67.7% of the public float.
How much of Immuneering do insiders own?
Insiders, such as officers and directors, own about 14.24% of IMRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.